Art

J-GLOBAL ID：201902271220163711   Reference number：19A0729124

Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study

難治性ネフローゼ症候群の小児における周期的反復リツキシマブ投与:2年間の多施設観察研究【JST・京大機械翻訳】

Author (11)： Takahashi Toshiyuki (Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan) ,  Okamoto Takayuki (Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan) ,  Sato Yasuyuki (Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan) ,  Yamazaki Takeshi (Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan) ,  Hayashi Asako (Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan) ,  Aoyagi Hayato (Department of Pediatrics, Obihiro Kyokai Hospital, Obihiro, Japan) ,  Ueno Michihiko (Department of Pediatrics, Nikko Memorial Hospital, Muroran, Japan) ,  Kobayashi Norio (Department of Pediatrics, Oji General Hospital, Tomakomai, Japan) ,  Uetake Kimiaki (Department of Pediatrics, Obihiro Kosei Hospital, Obihiro, Japan) ,  Nakanishi Masanori (Department of Pediatrics, Kushiro Red Cross Hospital, Kushiro, Japan) ,  Ariga Tadashi (Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan)
Material： Pediatric Nephrology
Volume： 34  Issue： 1  Page： 87-96  Publication year： 2019 
JST Material Number： W4836A  ISSN： 0931-041X  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Abstract/Point： Rituximab (RTX) is effective i...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0729124&from=J-GLOBAL&jstjournalNo=W4836A") }}

Thesaurus term： human(primates) ,  safety ,  *child ,  granulocytopenia ,  recurrence ,  *administration(biology) ,  *nephrotic syndrome ,  steroid ,  complication ,  pulse therapy ,  side effect ,  nitrogen heterocyclic compound ,  ribonucleoside ,  carboxamide ,  hydroxy acid
Semi thesaurus term： エンドポイント ,  カルシニューリン阻害剤 ,  *リツキシマブ ,  *難治性ネフローゼ症候群 , 【Automatic Indexing@JST】

Author keywords (6)： Nephrotic syndrome ,  Children ,  Rituximab ,  Repeated administration ,  Mizoribine ,  Calcineurin inhibitor

JST classification (3)： Drug therapy(=pharmacotherapy)for urogenital diseases  (GM05020V) ,  Urogenital diseases  (GM03000L) ,  Surgical treatment for urogenital diseases  (GM05030G)

Substance index (1)： Mizoribine

Terms in the title (8)： 難治性ネフローゼ症候群 ,  小児 ,  反復 ,  リツキシマブ ,  投与 ,  施設 ,  観察 ,  研究